The FemTech Investor Roundtable | Application
Strategic Alignment for Women’s Health Leaders
The FemTech Capital Pivot:
Bridging the Funding Gap through Evidence Maturity
The FemTech Investor Roundtable is an exclusive, invitation-only forum at the MTI25 Helsinki Summit. It is designed for founders and research leads who recognise that bridging the “FemTech Gap” requires more than a pitch—it requires Institutional Evidence Maturity. By applying, you are entering a process focused on technical de-risking and precision matchmaking with capital partners who specialise in the women’s health monetisation arc.
This roundtable is designed to bridge the structural funding gap by focusing on Evidence Maturity and strategic alignment for the 2026 fiscal year.
Complete Application Form
Fill in the form below and submit the application.
Stay tuned
Wait for the results of the application process.
Get Invitation
Invitation to the Roundtable when approved.
Participation Framework
For Innovators (Founders & Research Leads)
-
Strategic Red-Teaming: Secure a diagnostic audit of your “Path to Payment” logic.
-
Valuation Protection: Stress-test your regulatory trajectory against institutional due diligence standards.
-
Capital Access: Direct engagement with specialized FemTech and Life Science VCs.
For Capital Partners (Institutional & Private Investors)
-
Vetted Deal Flow: Access deep-tech ventures that have undergone the Investor Readiness (IRSc) diagnostic.
-
Evidence-First Portfolios: Evaluate companies proactively aligning with 2026 FDA/EUDAMED mandates.
-
First-Look Advantage: Early access to high-potential EIC-funded FemTech projects.
Roundtable Seat Finalisation Requirement
To maintain the focus and quality of this exclusive assembly, a reserved seat is contingent upon summit accreditation.
Applicants must hold, or commit to securing upon approval, one of the following MTI25 Summit ticket categories:
-
Founders: A “Standard Pass” or “Exhibitor/Innovation Pod” credential.
-
Investors: A verified “Investor Pass” (subject to accredited status).
The Selection Process
- Submission of Intent: Complete the qualification form below.
- Credential Verification: Our team reviews your sector focus and Evidence Maturity (Founders) or Fund Status (Investors).
- Seat Confirmation: Upon approval, your seat is finalized alongside your MTI25 Summit registration.
Application Form
Please see detailled instructions to fill the form below.
MTI26 Investor Roundtable: Application Instructions
The FemTech Capital Pivot:
Bridging the Funding Gap through Evidence Maturity
ATTENTION: This is an application for qualification, not a registration form. Submission of this form confirms your interest in joining this highly exclusive, curated roundtable (limited to 20 seats). The Steering Committee will review all submissions based on strategic relevance and seniority.
Important Deadlines and Requirements
-
Application Deadline: 27th February 2026.
-
Rolling Acceptance: Approved places are filled immediately upon qualification. We advise prompt submission as the roundtable will close once 20 seats are confirmed.
-
Ticket Requirement: If approved, you must purchase an Investor Pass, Startup & SME Pass, or Professional Pass to finalise your reserved seat. The Public Service and Media Passes do not qualify.
Instructions for Filling Out the Application Form
Applicant Profile
-
Purpose: To verify your professional identity and assess your required ticket tier.
-
Instructions: Please provide accurate and verifiable contact information. Your Current Professional Title and Organisation Type will be used to confirm your seniority and strategic fit for this high-level discussion.
Strategic Qualification (The Pivot Alignment)
-
Purpose: This section is the core of the vetting process. Your answers must be specific, strategic, and directly demonstrate your involvement in the deep-science, high-capital shift in women’s health. Do not submit general company descriptions.
-
Instructions: Responses should be concise (max 200 words per answer) and focus on tactical execution or high-level investment strategy, using objective examples (e.g., funding amounts, specific technologies, or clinical trial endpoints).
1. Current Scope of Influence
-
Investors/PE: Provide the size of your fund’s relevant AUM or investment focus (e.g., “Seed-stage MedTech”). Specify your level of decision-making authority for investments in the health sector.
-
Founders/Executives: State your company’s current funding stage (e.g., Series B, Public) and clearly define its primary focus.
2. Addressing the Deep Science Shift
-
Focus: Explain how your work aligns with the shift of capital towards Biopharma and regulated Diagnostics, which addresses the $360 billion chronic care market potential.
-
Response Content: Detail one specific recent initiative (investment, product launch, research breakthrough) that is designed to overcome historical barriers, such as using AI to classify complex disorders (like PCOS subtyping
3. The Technology Catalyst
-
Focus: Demonstrate how you are leveraging advanced technology to create objective, standardised data—the key element required for investor de-risking and regulatory success.
-
Response Content: Specifically mention the role of AI, Omics (e.g., Transcriptomics), or advanced sensor technology in your strategy, and explain the direct business or scientific value of the data you are generating (e.g., validating a clinical endpoint, improving IVF selection, or accelerating drug development).
Commitment & Submission
-
Commitment: By checking the box, you confirm your understanding that approval is conditional on purchasing the required MTI26 Summit ticket (Investor, Startup & SME, or Professional Pass).
-
Submission: Ensure all fields are complete before submission. You will be notified of the committee’s decision soon, please keep an eye on your email’s spam folder.
Useful Links